STOCK TITAN
  1. Home
  2. News
  3. RHHBY

Roche Holding AG - RHHBY STOCK NEWS

IMPACT
SENTIMENT
RHHBY : OTC
[Ad hoc announcement pursuant to Art. 53 LR] FDA approves Roche’s Vabysmo for the treatment of retinal vein occlusion (RVO)
fda approval
IMPACT
SENTIMENT
RHHBY : OTC
Roche collaborates with Ibex and Amazon Web Services to accelerate adoption of AI-enabled digital pathology solutions to help improve cancer diagnoses
AI
IMPACT
SENTIMENT
RHHBY : OTC
[Ad hoc announcement pursuant to Art. 53 LR] Roche enters into a definitive agreement to acquire Telavant including rights to novel TL1A directed antibody (RVT-3101) for the treatment of inflammatory bowel disease from Roivant
acquisition
IMPACT
SENTIMENT
RHHBY : OTC
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good sales growth despite decline in demand for COVID-19 products
covid-19
IMPACT
SENTIMENT
RHHBY : OTC
Roche IL-6 is the first immunoassay approved to aid sepsis diagnosis in newborns
IMPACT
SENTIMENT
RHHBY : OTC
Roche’s Alecensa reduces the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage non-small cell lung cancer
IMPACT
SENTIMENT
RHHBY : OTC
Late-breaking data for Roche’s BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis
IMPACT
SENTIMENT
RHHBY : OTC
New data for Roche’s OCREVUS show that after 10 years of treatment 77% of people with relapsing multiple sclerosis were free from disability progression and 92% continue to walk unaided
IMPACT
SENTIMENT
RHHBY : OTC
First-Ever Clinical Trial Exclusively in Black and Hispanic / Latinx People Living With Multiple Sclerosis Shows Genentech’s Ocrevus Effectively Manages Disease Activity
clinical trial
IMPACT
SENTIMENT
RHHBY : OTC
Roche’s OCREVUS twice-yearly, 10-minute subcutaneous injection was non-inferior to intravenous infusion and provided near-complete suppression of brain lesions
Stock RHHBY logo
Roche Holding AG

OTC:RHHBY

RHHBY Rankings

#37 Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

RHHBY Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Pharmaceuticals: Major, Health Technology, Manufacturing, Medicinal and Botanical Manufacturing
Switzerland
Basel